COSCIENS Biopharma Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $23.7M
Liabilities Breakdown FY2023
Total Liabilities: $2.7M
Asset Breakdown
Total Assets: $23.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.7M | 28.1% |
| Accounts Receivable | $290.0K | 1.2% |
| Inventory | $4.0M | 16.9% |
| Property, Plant & Equipment | $1.5M | 6.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $11.3M | 47.5% |
Liabilities Breakdown
Total Liabilities: $2.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.7M | 100.0% |